News
Spero Therapeutics, Inc. (NASDAQ: SPRO) Q2 2025 Earnings Call Transcript August 12, 2025 Spero Therapeutics, Inc. beats ...
The ADC market is rapidly advancing due to next-gen oncology therapeutics and increased R&D, offering significant opportunities for addressing treatment-resistant cancersDublin, Aug. 13, 2025 (GLOBE ...
HPV vaccination has been available since 2006 in the US, has been administered more than 270 million times globally, and has been proven to be safe and effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback